403 related articles for article (PubMed ID: 25962528)
21. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
Tsilifis C; Freeman AF; Gennery AR
J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
[TBL] [Abstract][Full Text] [Related]
22. A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity.
Béziat V; Li J; Lin JX; Ma CS; Li P; Bousfiha A; Pellier I; Zoghi S; Baris S; Keles S; Gray P; Du N; Wang Y; Zerbib Y; Lévy R; Leclercq T; About F; Lim AI; Rao G; Payne K; Pelham SJ; Avery DT; Deenick EK; Pillay B; Chou J; Guery R; Belkadi A; Guérin A; Migaud M; Rattina V; Ailal F; Benhsaien I; Bouaziz M; Habib T; Chaussabel D; Marr N; El-Benna J; Grimbacher B; Wargon O; Bustamante J; Boisson B; Müller-Fleckenstein I; Fleckenstein B; Chandesris MO; Titeux M; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Meyts I; Di Santo JP; Hovnanian A; Somer A; Ozen A; Rezaei N; Chatila TA; Abel L; Leonard WJ; Tangye SG; Puel A; Casanova JL
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29907691
[TBL] [Abstract][Full Text] [Related]
23. TH17 Cells in STAT3 Related Hyper-IgE Syndrome.
Sharma S; Saikia B; Goel S; Rawat A; Minz RW; Suri D; Chhabra S; Singh S
Indian J Pediatr; 2016 Oct; 83(10):1104-8. PubMed ID: 27226025
[TBL] [Abstract][Full Text] [Related]
24. STAT3-Mediated Transcriptional Regulation of Osteopontin in STAT3 Loss-of-Function Related Hyper IgE Syndrome.
Goel S; Sahu S; Minz RW; Singh S; Suri D; Oh YM; Rawat A; Sehgal S; Saikia B
Front Immunol; 2018; 9():1080. PubMed ID: 29868029
[TBL] [Abstract][Full Text] [Related]
25. ZNF341 controls STAT3 expression and thereby immunocompetence.
Frey-Jakobs S; Hartberger JM; Fliegauf M; Bossen C; Wehmeyer ML; Neubauer JC; Bulashevska A; Proietti M; Fröbel P; Nöltner C; Yang L; Rojas-Restrepo J; Langer N; Winzer S; Engelhardt KR; Glocker C; Pfeifer D; Klein A; Schäffer AA; Lagovsky I; Lachover-Roth I; Béziat V; Puel A; Casanova JL; Fleckenstein B; Weidinger S; Kilic SS; Garty BZ; Etzioni A; Grimbacher B
Sci Immunol; 2018 Jun; 3(24):. PubMed ID: 29907690
[TBL] [Abstract][Full Text] [Related]
26. Clinical Profile of Hyper-IgE Syndrome in India.
Saikia B; Rawat A; Minz RW; Suri D; Pandiarajan V; Jindal A; Sahu S; Karim A; Desai M; Taur PD; Pandrowala A; Gowri V; Madkaikar M; Dalvi A; Yadav RM; Lashkari HP; Raj R; Uppuluri R; Swaminathan VV; Bhattad S; Cyril G; Kumar H; Shukla A; Kalra M; Govindaraj G; Singh S
Front Immunol; 2021; 12():626593. PubMed ID: 33717144
[No Abstract] [Full Text] [Related]
27. Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis.
Abusleme L; Diaz PI; Freeman AF; Greenwell-Wild T; Brenchley L; Desai JV; Ng WI; Holland SM; Lionakis MS; Segre JA; Kong HH; Moutsopoulos NM
JCI Insight; 2018 Sep; 3(17):. PubMed ID: 30185668
[TBL] [Abstract][Full Text] [Related]
28. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children.
Hagl B; Heinz V; Schlesinger A; Spielberger BD; Sawalle-Belohradsky J; Senn-Rauh M; Magg T; Boos AC; Hönig M; Schwarz K; Dückers G; von Bernuth H; Pache C; Karitnig-Weiss C; Belohradsky BH; Frank J; Niehues T; Wahn V; Albert MH; Wollenberg A; Jansson AF; Renner ED
Pediatr Allergy Immunol; 2016 Mar; 27(2):177-84. PubMed ID: 26592211
[TBL] [Abstract][Full Text] [Related]
29. Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.
Hsu AP; Sowerwine KJ; Lawrence MG; Davis J; Henderson CJ; Zarember KA; Garofalo M; Gallin JI; Kuhns DB; Heller T; Milner JD; Puck JM; Freeman AF; Holland SM
J Allergy Clin Immunol; 2013 Jun; 131(6):1586-93. PubMed ID: 23623265
[TBL] [Abstract][Full Text] [Related]
30. Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome.
Farmand S; Kremer B; Häffner M; Pütsep K; Bergman P; Sundin M; Ritterbusch H; Seidl M; Follo M; Henneke P; Henriques-Normark B
Eur J Immunol; 2018 Dec; 48(12):1975-1988. PubMed ID: 30315710
[TBL] [Abstract][Full Text] [Related]
31. Somatic mosaicism in B cells of a patient with autosomal dominant hyper IgE syndrome.
Alcántara-Montiel JC; Staines-Boone T; López-Herrera G; Berrón-Ruiz L; Borrego-Montoya CR; Santos-Argumedo L
Eur J Immunol; 2016 Oct; 46(10):2438-2443. PubMed ID: 27488252
[TBL] [Abstract][Full Text] [Related]
32. Dominant-negative signal transducer and activator of transcription (STAT)3 variants in adult patients: A single center experience.
Shamriz O; Rubin L; Simon AJ; Lev A; Barel O; Somech R; Korem M; Matza Porges S; Freund T; Hagin D; Garty BZ; Nahum A; Molho Pessach V; Tal Y
Front Immunol; 2022; 13():1044933. PubMed ID: 36605204
[TBL] [Abstract][Full Text] [Related]
33. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome.
Woellner C; Gertz EM; Schäffer AA; Lagos M; Perro M; Glocker EO; Pietrogrande MC; Cossu F; Franco JL; Matamoros N; Pietrucha B; Heropolitańska-Pliszka E; Yeganeh M; Moin M; Español T; Ehl S; Gennery AR; Abinun M; Breborowicz A; Niehues T; Kilic SS; Junker A; Turvey SE; Plebani A; Sánchez B; Garty BZ; Pignata C; Cancrini C; Litzman J; Sanal O; Baumann U; Bacchetta R; Hsu AP; Davis JN; Hammarström L; Davies EG; Eren E; Arkwright PD; Moilanen JS; Viemann D; Khan S; Maródi L; Cant AJ; Freeman AF; Puck JM; Holland SM; Grimbacher B
J Allergy Clin Immunol; 2010 Feb; 125(2):424-432.e8. PubMed ID: 20159255
[TBL] [Abstract][Full Text] [Related]
34. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
[TBL] [Abstract][Full Text] [Related]
35. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
[TBL] [Abstract][Full Text] [Related]
36. A mouse model of HIES reveals pro- and anti-inflammatory functions of STAT3.
Steward-Tharp SM; Laurence A; Kanno Y; Kotlyar A; Villarino AV; Sciume G; Kuchen S; Resch W; Wohlfert EA; Jiang K; Hirahara K; Vahedi G; Sun HW; Feigenbaum L; Milner JD; Holland SM; Casellas R; Powrie F; O'Shea JJ
Blood; 2014 May; 123(19):2978-87. PubMed ID: 24632714
[TBL] [Abstract][Full Text] [Related]
37. Generation of human induced pluripotent stem cell lines (NIHTVBi011-A, NIHTVBi012-A, NIHTVBi013-A) from autosomal dominant Hyper IgE syndrome (AD-HIES) patients carrying STAT3 mutation.
Jin H; Yu Z; Navarengom K; Liu Y; Dmitrieva N; Hsu AP; Schwartzbeck R; Cudrici C; Ferrante EA; Yang D; Holland SM; Freeman AF; Boehm M; Chen G
Stem Cell Res; 2019 Dec; 41():101586. PubMed ID: 31707214
[TBL] [Abstract][Full Text] [Related]
38. TNF overproduction impairs epithelial staphylococcal response in hyper IgE syndrome.
Myles IA; Anderson ED; Earland NJ; Zarember KA; Sastalla I; Williams KW; Gough P; Moore IN; Ganesan S; Fowler CJ; Laurence A; Garofalo M; Kuhns DB; Kieh MD; Saleem A; Welch PA; Darnell DA; Gallin JI; Freeman AF; Holland SM; Datta SK
J Clin Invest; 2018 Aug; 128(8):3595-3604. PubMed ID: 30035749
[TBL] [Abstract][Full Text] [Related]
39. Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells.
Saito M; Nagasawa M; Takada H; Hara T; Tsuchiya S; Agematsu K; Yamada M; Kawamura N; Ariga T; Tsuge I; Nonoyama S; Karasuyama H; Minegishi Y
J Exp Med; 2011 Feb; 208(2):235-49. PubMed ID: 21300911
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
